Provided by Tiger Trade Technology Pte. Ltd.

XILIO THERAPEUTICS, INC.

8.39
-0.0933-1.10%
Volume:10.09K
Turnover:84.33K
Market Cap:48.50M
PE:-2.00
High:8.53
Open:8.30
Low:8.21
Close:8.48
52wk High:16.52
52wk Low:6.47
Shares:5.78M
Float Shares:3.17M
Volume Ratio:0.47
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1900
EPS(LYR):-15.2374
ROE:-132.53%
ROA:-23.24%
PB:1.37
PE(LYR):-0.55

Loading ...

Insider Move at Xilio Therapeutics Sparks Fresh Investor Interest

TIPRANKS
·
Mar 31

Xilio director Shannon James Samuel buys USD 0.04 million common shares

Reuters
·
Mar 31

Xilio Therapeutics Inc : Leerink Partners Adjusts Target Price to $20 From $2 to Reflect 1-for-14 Reverse Stock Split

THOMSON REUTERS
·
Mar 24

Xilio Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 23

BUZZ-U.S. STOCKS ON THE MOVE-Energy firms, Cencora, Stryker

Reuters
·
Mar 23

BUZZ-Xilio rises after surprise quarterly profit

Reuters
·
Mar 23

Xilio Therapeutics Inc: Q4 Net Income USD 10.36 Million

THOMSON REUTERS
·
Mar 23

Xilio Therapeutics posts Q4 profit on higher collaboration revenue

Reuters
·
Mar 23

Xilio Therapeutics Q4 license revenue rose 100% to USD 14 million, net income was USD 10 million

Reuters
·
Mar 23

Xilio Therapeutics Inc - Cash Runway Extended Through End of 2027

THOMSON REUTERS
·
Mar 23

Press Release: Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Mar 23

Xilio Therapeutics to present XTX601 CLDN18.2 masked T cell engager data at AACR Annual Meeting

Reuters
·
Mar 18

Xilio Therapeutics Inc trading halted, news pending

TIPRANKS
·
Mar 14

Xilio Therapeutics to implement 1-for-14 reverse stock split March 13, 2026

Reuters
·
Mar 12

Xilio Therapeutics Announces 1-for-14 Reverse Stock Split

THOMSON REUTERS
·
Mar 12

Xilio Therapeutics Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
Mar 06

Xilio Therapeutics announces inducement grants

TIPRANKS
·
Mar 02

BRIEF-Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Mar 02

Xilio Therapeutics Grants Inducement Stock Options to New Employees

Reuters
·
Mar 02

Press Release: Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dow Jones
·
Mar 02